InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,395.20
(
0.38%
)
Dow Jones
42,124.65
(
0.15%
)
Brent Oil
74.80
(
1.44%
)
Bitcoin
63,858.34
(
0.84%
)
Post# of 4273
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Opti Mist

Send PM Follow Ignore
Followers 52
Posts 4109
Boards Moderated 0
Alias Born 07/03/2005

Opti Mist

Re: None

Wednesday, 01/10/2018 6:57:34 AM

Wednesday, January 10, 2018 6:57:34 AM

Post# of 4273
Synergy Pharma: Dilutive Financing Appears Likely Before Inflection Point
Jan. 10, 2018 5:02 AM ET|Summary
Cash position suggests Synergy Pharma needs to raise more money before next $100 million loan tranche.
New CEO has an opportunity to end financing risks to new investors.
The company is near an inflection point in sales and costs that will reduce cash burn going forward.
Synergy Pharma (SGYP) continues to wade through a volatile drug launch due to questionable internal decisions. The company botched the drug launch financing, but the investment thesis isn't altered with the recent replacement of the CEO.

https://seekingalpha.com/article/4136488-synergy-pharma-dilutive-financing-appears-likely-inflection-point

Opti

Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up